Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Design Therapeutics Inc shares valued at $23,864 were sold by Prasad Deepa on Dec 18 ’24. At $6.27 per share, Prasad Deepa sold 3,806 shares. The insider’s holdings dropped to 20,000 shares worth approximately $0.1 million following the completion of this transaction.
Also, William Arsani sold 814,874 shares, netting a total of over 3,463,214 in proceeds. Following the sale of shares at $4.25 each, the insider now holds 0 shares.
Before that, Logos SPV 1 LP had added 814,874 shares to its account. In a trade valued at $3,455,066, the Director bought Design Therapeutics Inc shares for $4.24 each.
As published in a research note from Piper Sandler on May 07, 2024, Design Therapeutics Inc [DSGN] has been rated up from a Neutral to an Overweight and the price target has been revised to $12 from $6. Analysts at Piper Sandler downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid November. As of August 15, 2023, Wedbush has decreased its “an Outperform” rating to a “Neutral” for DSGN. Earlier on August 15, 2023, SVB Securities downgraded its rating. Their new recommendation was “a Market perform” for DSGN stock which previously was a “an Outperform”.
Analyzing DSGN Stock Performance
During the last five days, there has been a drop of approximately -17.75%. Over the course of the year, Design Therapeutics Inc shares have dropped approximately -17.75%. Shares of the company reached a 52-week high of $6.81 on 01/06/25 and a 52-week low of $5.05 on 01/08/25. A 50-day SMA is recorded $6.03, while a 200-day SMA reached $4.81. Nevertheless, trading volume fell to 0.28 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Design Therapeutics Inc (DSGN)
According to the 24-hour chart, there is a support level at 4.74, which, if violated, would cause prices to drop to 4.41. In the upper region, resistance lies at 5.72. The next price resistance is at 6.36. RSI (Relative Strength Index) is 36.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.37, which suggests the price will decrease in the coming days. Percent R is at 98.58%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
